Privi Speciality Chemicals Ltd (PRIVISCL) Q1 FY27 Results Analysis: PAT Surges 36%, Margin Misses Guidance

Privi Speciality Chemicals Ltd's Q1 FY27 numbers came in mixed, with revenue of Rs. 666.22 Cr (+19.22% YoY) and PAT growth of +35.97% YoY. Here's a quick read of what worked, what to watch, and what management said.

Quarter Snapshot

Privi Speciality Chemicals reported 19.22% YoY revenue growth to Rs.666.22 Cr, with PAT attributable to owners surging 35.97% YoY. However, consolidated EBITDA margin of 22.86% missed the guided 24-26% band due to raw material cost pressure. The subsidiary drag virtually disappeared, confirming the PRIGIV JV's profitability milestone, while forex gains boosted other income.

Key Investment Insights

Key Positives

• Revenue grew 19.22% YoY to Rs.666.22 Cr.
• PAT attributable to owners grew 35.97% YoY to Rs.84.21 Cr.
• Subsidiary drag narrowed from Rs.6.76 Cr to Rs.0.06 Cr, with PRIGIV turning profitable.
• Finance costs declined 29.23% YoY to Rs.16.74 Cr.
• Standalone EBITDA margin of 24.24% remained within the 24-26% guided band.

Risk Factors

• Consolidated EBITDA margin of 22.86% fell below the guided 24-26% band.
• Raw material cost pressure: cost of materials as % of revenue rose 485 bps YoY to 59.57%.
• Revenue declined 7.66% sequentially, though Q1 is seasonally weak.
• Elevated other income from forex gains is volatile and may not be sustainable.